Ketamine used in the therapy of depressive disorders impacts protein profile, proliferation rate, and phagocytosis resistance of enterococci

[1] Mion G. History of anaesthesia: The ketamine story - past, present and future. Eur J Anaesthesiol. 2017; 34: 571–575. MionG History of anaesthesia: The ketamine story - past, present and future Eur J Anaesthesiol 2017 34 571 575 10.1097/EJA.000000000000063828731926 Search in Google Scholar

[2] Ilkjaer S, Petersen KL, Brennum J, Wernberg M, Dahl JB. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. Br J Anaesth. 1996; 76: 829–834. IlkjaerS PetersenKL BrennumJ WernbergM DahlJB Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans Br J Anaesth 1996 76 829 834 10.1093/bja/76.6.8298679358 Search in Google Scholar

[3] Wachtel H, Turski L. Glutamate: A new target in schizophrenia? Trends Pharmacol Sci. 1990; 11: 219–220. WachtelH TurskiL Glutamate: A new target in schizophrenia? Trends Pharmacol Sci 1990 11 219 220 10.1016/0165-6147(90)90243-22166367 Search in Google Scholar

[4] Gosek P, Chojnacka M, Bieńkowski P, Świecicki Ł. Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy. Psychiatr Pol. 2014; 48: 49–58. GosekP ChojnackaM BieńkowskiP ŚwiecickiŁ Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy Psychiatr Pol 2014 48 49 58 10.12740/PP/20566 Search in Google Scholar

[5] Schwartz J, Murrough JW, Iosifescu DV. Ketamine for treatment-resistant depression: Recent developments and clinical applications. Evid Based Ment Health. 2016; 19: 35–38. SchwartzJ MurroughJW IosifescuDV Ketamine for treatment-resistant depression: Recent developments and clinical applications Evid Based Ment Health 2016 19 35 38 10.1136/eb-2016-10235527053196 Search in Google Scholar

[6] Serafini G, Howland R, Rovedi F, Girardi P, Amore M. The role of ketamine in treatment-resistant depression: A systematic review. Curr Neuropharmacol. 2014; 12: 444–461. SerafiniG HowlandR RovediF GirardiP AmoreM The role of ketamine in treatment-resistant depression: A systematic review Curr Neuropharmacol 2014 12 444 461 10.2174/1570159X12666140619204251424303425426012 Search in Google Scholar

[7] Bobo WV, Voort JLV, Croarkin PE, Leung JG, Tye SJ, Frye MA. Ketamine for treatment-resistant unipolar and bipolar major depression: Critical review and implications for clinical practice. Depress Anxiety. 2016; 33: 698–710. BoboWV VoortJLV CroarkinPE LeungJG TyeSJ FryeMA Ketamine for treatment-resistant unipolar and bipolar major depression: Critical review and implications for clinical practice Depress Anxiety 2016 33 698 710 10.1002/da.2250527062450 Search in Google Scholar

[8] Nowak W, Grendas LN, Sanmarco LM, Estecho IG, Arena ÁR, Eberhardt N, Rodante DE, Aoki MP, Daray FM, Carrera Silva EA, Errasti AE. Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR. EBioMedicine. 2019; 50: 290–305. NowakW GrendasLN SanmarcoLM EstechoIG ArenaÁR EberhardtN RodanteDE AokiMP DarayFM Carrera SilvaEA ErrastiAE Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR EBioMedicine 2019 50 290 305 10.1016/j.ebiom.2019.10.063692122631753725 Search in Google Scholar

[9] Szałach ŁP, Lisowska KA, Cubała WJ. The influence of antidepressants on the immune system. Arch Immunol Ther Exp. 2019; 67: 143–151. SzałachŁP LisowskaKA CubałaWJ The influence of antidepressants on the immune system Arch Immunol Ther Exp 2019 67 143 151 10.1007/s00005-019-00543-8650909331032529 Search in Google Scholar

[10] Begec Z, Yucel A, Yakupogullari Y, Erdogan MA, Duman Y, Durmus M, Ersoy MO. The antimicrobial effects of ketamine combined with propofol: An in vitro study. Braz J Anesthesiol. 2013; 63: 461–465. BegecZ YucelA YakupogullariY ErdoganMA DumanY DurmusM ErsoyMO The antimicrobial effects of ketamine combined with propofol: An in vitro study Braz J Anesthesiol 2013 63 461 465 10.1016/j.bjane.2012.09.00424565343 Search in Google Scholar

[11] Gocmen S, Buyukkocak U, Caglayan O. In vitro investigation of the antibacterial effect of ketamine. Ups J Med Sci. 2008; 113: 39–46. GocmenS BuyukkocakU CaglayanO In vitro investigation of the antibacterial effect of ketamine Ups J Med Sci 2008 113 39 46 10.3109/2000-1967-21118521797 Search in Google Scholar

[12] Kruszewska H, Zareba T, Tyski S. Search of antimicrobial activity of selected non-antibiotic drugs. Acta Pol Pharm. 2002; 59: 436–439. KruszewskaH ZarebaT TyskiS Search of antimicrobial activity of selected non-antibiotic drugs Acta Pol Pharm 2002 59 436 439 Search in Google Scholar

[13] Anders HJ, Lichtnekert J, Allam R. Interferon-α and -β in kidney inflammation. Kidney Int. 2010; 77: 848–854. AndersHJ LichtnekertJ AllamR Interferon-α and -β in kidney inflammation Kidney Int 2010 77 848 854 10.1038/ki.2010.7120237459 Search in Google Scholar

[14] Doss SA, Tillotson GS, Amyes SGB. Effect of sub-inhibitory concentrations of antibiotics on the virulence of Staphylococcus aureus. J Appl Bacteriol. 1993; 75: 123–128. DossSA TillotsonGS AmyesSGB Effect of sub-inhibitory concentrations of antibiotics on the virulence of Staphylococcus aureus J Appl Bacteriol 1993 75 123 128 10.1111/j.1365-2672.1993.tb02756.x8407672 Search in Google Scholar

[15] Hacker J, Ott M, Hof H. Effects of low, subinhibitory concentrations of antibiotics on expression of a virulence gene cluster of pathogenic Escherichia coli by using a wild-type gene fusion. Int J Antimicrob Agents. 1993; 2: 263–270. HackerJ OttM HofH Effects of low, subinhibitory concentrations of antibiotics on expression of a virulence gene cluster of pathogenic Escherichia coli by using a wild-type gene fusion Int J Antimicrob Agents 1993 2 263 270 10.1016/0924-8579(93)90060-I18611540 Search in Google Scholar

[16] Lück PC, Schmitt JW, Hengerer A, Helbig JH. Subinhibitory concentrations of antimicrobial agents reduce the uptake of Legionella pneumophila into Acanthamoeba castellanii and U937 cells by altering the expression of virulence-associated antigens. Antimicrob Agents and Chemother. 1998; 42: 2870–2876. LückPC SchmittJW HengererA HelbigJH Subinhibitory concentrations of antimicrobial agents reduce the uptake of Legionella pneumophila into Acanthamoeba castellanii and U937 cells by altering the expression of virulence-associated antigens Antimicrob Agents and Chemother 1998 42 2870 2876 10.1128/AAC.42.11.28701059589797218 Search in Google Scholar

[17] Nichterlein T, Domann E, Kretschmar M, Bauer M, Hlawatsch A, Hof H, Chakraborty T. Subinhibitory concentrations of β-lactams and other cell-wall antibiotics inhibit listeriolysin production by Listeria monocytogenes. Int J of Antimicrob Agents. 1996; 7: 75–81. NichterleinT DomannE KretschmarM BauerM HlawatschA HofH ChakrabortyT Subinhibitory concentrations of β-lactams and other cell-wall antibiotics inhibit listeriolysin production by Listeria monocytogenes Int J of Antimicrob Agents 1996 7 75 81 10.1016/0924-8579(96)00014-318611740 Search in Google Scholar

[18] Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate Jr CA, et al. Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms. Pharmacol Rev. 2018; 70: 621–660. ZanosP MoaddelR MorrisPJ RiggsLM HighlandJN GeorgiouP PereiraEFR AlbuquerqueEX ThomasCJ ZarateCAJr Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms Pharmacol Rev 2018 70 621 660 10.1124/pr.117.015198602010929945898 Search in Google Scholar

[19] Getachew B, Aubee JI, Schottenfeld RS, Csoka AB, Thompson KM, Tizabi Y. Ketamine interactions with gut-microbiota in rats: Relevance to its antidepressant and anti-inflammatory properties. BMC Microbiol. 2018; 18: 222. GetachewB AubeeJI SchottenfeldRS CsokaAB ThompsonKM TizabiY Ketamine interactions with gut-microbiota in rats: Relevance to its antidepressant and anti-inflammatory properties BMC Microbiol 2018 18 222 10.1186/s12866-018-1373-7630395430579332 Search in Google Scholar

[20] Berk M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013; 11: 200. BerkM WilliamsLJ JackaFN O’NeilA PascoJA MoylanS AllenNB StuartAL HayleyAC ByrneML MaesM So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 2013 11 200 10.1186/1741-7015-11-200384668224228900 Search in Google Scholar

[21] Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: A meta-analysis of 30 studies. Biol Psychiatry. 2013; 74: 15–25. ModabberniaA TaslimiS BrietzkeE AshrafiM Cytokine alterations in bipolar disorder: A meta-analysis of 30 studies Biol Psychiatry 2013 74 15 25 10.1016/j.biopsych.2013.01.00723419545 Search in Google Scholar

[22] Zarate CA, Brutsche N, Laje G, Luckenbaugh DA, Venkata SLV, Ramamoorthy A, Moaddel R, Wainer IW. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry. 2012; 72: 331–338. ZarateCA BrutscheN LajeG LuckenbaughDA VenkataSLV RamamoorthyA MoaddelR WainerIW Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression Biol Psychiatry 2012 72 331 338 10.1016/j.biopsych.2012.03.004344225522516044 Search in Google Scholar

[23] Strohalm M, Hassman M, Košata B, Kodíček M. mMass data miner: An open source alternative for mass spectrometric data analysis. Rapid Commun Mass Spectrom. 2008; 22: 905–908. StrohalmM HassmanM KošataB KodíčekM mMass data miner: An open source alternative for mass spectrometric data analysis Rapid Commun Mass Spectrom 2008 22 905 908 10.1002/rcm.344418293430 Search in Google Scholar

[24] Stępień-Pyśniak D, Hauschild T, Różański P, Marek A. MALDI-TOF mass spectrometry as a useful tool for identification of Enterococcus spp. from wild birds and differentiation of closely related species. J Microbiol Biotechnol. 2017; 27: 1128–1137. Stępień-PyśniakD HauschildT RóżańskiP MarekA MALDI-TOF mass spectrometry as a useful tool for identification of Enterococcus spp. from wild birds and differentiation of closely related species J Microbiol Biotechnol 2017 27 1128 1137 10.4014/jmb.1612.1203628285496 Search in Google Scholar

[25] Chan KL, Cathomas F, Russo SJ. Central and peripheral inflammation link metabolic syndrome and major depressive disorder. Physiology. 2019; 34: 123–133. ChanKL CathomasF RussoSJ Central and peripheral inflammation link metabolic syndrome and major depressive disorder Physiology 2019 34 123 133 10.1152/physiol.00047.2018658683230724127 Search in Google Scholar

[26] Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018; 23: 801–811. ZanosP GouldTD Mechanisms of ketamine action as an antidepressant Mol Psychiatry 2018 23 801 811 10.1038/mp.2017.255599940229532791 Search in Google Scholar

[27] Comerlato CB, Zhang X, Walker K, Brandelli A, Figeys D. Comparative proteomic analysis reveals metabolic variability of probiotic Enterococcus durans during aerobic and anaerobic cultivation. J Proteomics. 2020; 220: 103764. ComerlatoCB ZhangX WalkerK BrandelliA FigeysD Comparative proteomic analysis reveals metabolic variability of probiotic Enterococcus durans during aerobic and anaerobic cultivation J Proteomics 2020 220 103764 10.1016/j.jprot.2020.10376432247174 Search in Google Scholar

[28] Toyota S, Moriyama M, Otake T, Kono J, Shudou Y, Satake T, Seki K, Masuda S, Amaki Y. Effect of anaesthetic agents on the phagocytic function of human polymorphonuclear leukocytes through analysis with a phagocytic plaque method. Inflamm Res. 1995; 44: 204–206. ToyotaS MoriyamaM OtakeT KonoJ ShudouY SatakeT SekiK MasudaS AmakiY Effect of anaesthetic agents on the phagocytic function of human polymorphonuclear leukocytes through analysis with a phagocytic plaque method Inflamm Res 1995 44 204 206 10.1007/BF017822597655994 Search in Google Scholar

[29] Krumholz W, Endrass J, Hempelmann G. Inhibition of phagocytosis and killing of bacteria by anaesthetic agents in vitro. Br J Anaesth. 1995; 75: 66–70. KrumholzW EndrassJ HempelmannG Inhibition of phagocytosis and killing of bacteria by anaesthetic agents in vitro Br J Anaesth 1995 75 66 70 10.1093/bja/75.1.667669473 Search in Google Scholar

[30] Son KA, Kang JH, Yang MP. Ketamine inhibits the phagocytic responses of canine peripheral blood polymorphonuclear cells through the upregulation of prostaglandin E2 in peripheral blood mononuclear cells in vitro. Res Vet Sci. 2009; 87: 41–46. SonKA KangJH YangMP Ketamine inhibits the phagocytic responses of canine peripheral blood polymorphonuclear cells through the upregulation of prostaglandin E2 in peripheral blood mononuclear cells in vitro Res Vet Sci 2009 87 41 46 10.1016/j.rvsc.2008.12.00419167017 Search in Google Scholar